| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1056.2B | ¥1029.4B | +2.6% |
| Operating Income | ¥55.1B | ¥56.2B | -1.9% |
| Ordinary Income | ¥54.7B | ¥53.5B | +2.2% |
| Net Income | ¥35.7B | ¥32.9B | +8.4% |
| ROE | 15.1% | 14.5% | - |
FY2025 Q3 (9-month cumulative) results show revenue of 105.6B yen (YoY +2.6%), operating income of 5.5B yen (YoY -1.9%), ordinary income of 5.5B yen (YoY +2.2%), and net income attributable to owners of 3.6B yen (YoY +8.4%). The company achieved top-line growth while operating profit declined slightly, but ordinary income and net income both improved YoY, indicating a revenue up/profit mixed pattern with bottom-line improvement supported by non-operating income and tax factors.
Revenue increased 2.7B yen YoY to 105.6B yen, driven by growth across all three reporting segments. Medical segment revenue rose 3.4% YoY from 53.4B yen to 55.2B yen, with medical contracting services expanding from 47.1B yen to 49.1B yen while medical dispatching declined slightly from 5.1B yen to 4.8B yen. Elderly Care segment revenue grew 1.0% YoY from 41.9B yen to 42.3B yen, showing steady demand for nursing care services. Children segment revenue increased 6.2% YoY from 7.6B yen to 8.1B yen, marking the highest growth rate among segments. The Medical segment remains the core business, accounting for 52.3% of total revenue.
Operating income declined 1.1B yen YoY from 5.6B yen to 5.5B yen despite revenue growth, indicating margin compression. Operating margin declined to 5.2% from 5.5% YoY, a decrease of 0.3 percentage points. Gross profit margin stood at 16.4%, significantly below typical industry benchmarks, suggesting price competition or cost structure challenges. Selling, general and administrative expenses increased from 11.5B yen to 11.8B yen, growing at 2.6%, roughly matching revenue growth rate but offsetting gross profit expansion.
Ordinary income improved to 5.5B yen from 5.4B yen YoY despite lower operating income, benefiting from improved non-operating income. Non-operating income contribution was approximately 0.2B yen positive (ordinary income of 5.5B yen minus operating income of 5.5B yen). Net income grew 8.4% YoY from 3.3B yen to 3.6B yen, outpacing ordinary income growth due to lower tax burden or extraordinary items. The divergence between operating income (declining) and net income (rising) reflects non-operating and below-the-line factors supporting bottom-line performance.
This represents a revenue up/profit mixed pattern, where top-line growth was achieved across all segments but operating efficiency declined, while non-operating factors and tax effects supported net income growth.
Medical segment generated revenue of 55.2B yen and operating income of 3.1B yen, representing 52.3% of total revenue and 56.2% of total segment operating profit. This segment functions as the core business with operating margin of 5.6%, above the company average. Within Medical, contracting services accounted for 49.1B yen while dispatching services contributed 4.8B yen, with contracting showing stronger growth momentum.
Elderly Care segment recorded revenue of 42.3B yen and operating income of 2.3B yen, contributing 40.0% of revenue and 41.5% of segment operating profit. Operating margin of 5.4% was slightly below the Medical segment, reflecting potentially tighter pricing or higher cost structures in nursing care services.
Children segment achieved revenue of 8.1B yen and operating income of 0.1B yen, representing 7.7% of revenue but only 2.3% of segment operating profit. Operating margin of 1.6% was materially lower than other segments, indicating this remains a developing business with limited profitability. The segment showed highest revenue growth rate at 6.2% YoY but profitability improvement remains a challenge.
Margin differences between segments are material, with Medical and Elderly Care operating at 5-6% margins while Children operates at sub-2% margin, suggesting different competitive dynamics and cost structures across service categories.
[Profitability] ROE of 15.1% substantially exceeds the company's historical levels and industry median of 8.2%, driven primarily by high financial leverage of 2.91x and strong asset turnover of 1.54x rather than net profit margin of 3.4%. Operating margin of 5.2% declined 0.3 percentage points from 5.5% YoY, indicating margin compression despite revenue growth. Net profit margin of 3.4% remains below industry median of 5.8%, reflecting the company's lower profitability structure. Gross profit margin of 16.4% is notably low, suggesting constrained pricing power or elevated cost base. [Cash Quality] Cash and deposits of 12.4B yen provide coverage of 24.8x against short-term debt, indicating extremely strong liquidity position. Operating cash flow of 5.4B yen represents 1.51x net income, confirming cash-backed earnings quality. [Investment Efficiency] Asset turnover of 1.54x significantly exceeds industry median of 0.68x, demonstrating efficient asset utilization typical of service businesses. Working capital turnover of 45-60 days range aligns with industry standards. Capital expenditure to depreciation ratio of 0.20x indicates substantial underinvestment in fixed assets, raising concerns about long-term capacity maintenance. [Financial Health] Equity ratio of 34.4% is below industry median of 59.0%, reflecting higher leverage strategy. Current ratio of 131.8% is below industry median of 213% but remains adequate for short-term obligations. Debt-to-equity ratio of 0.51x and interest coverage of 28.25x indicate manageable debt burden with strong servicing capability. Goodwill of 12.4B yen represents 52.4% of net assets, creating material impairment risk if acquired business performance deteriorates.
Operating cash flow of 5.4B yen represents 1.51x net income of 3.6B yen, confirming strong cash conversion and earnings quality. The cash conversion ratio exceeds industry median of 1.31x, indicating above-average ability to convert profits into cash. Investing cash flow of negative 0.7B yen was primarily driven by capital expenditures of 0.2B yen, with investment activity remaining constrained. The capex-to-depreciation ratio of 0.20x signals significant underinvestment, with capital spending at only one-fifth of depreciation, raising sustainability concerns about asset base maintenance. Free cash flow of 4.7B yen provides substantial financial flexibility. Financing cash flow reflected dividend payments and share buyback activity, with treasury stock increasing from negative 1.4B yen to negative 2.1B yen, representing 0.7B yen of share repurchases during the period. Cash position of 12.4B yen provides coverage of 24.8x against short-term liabilities, ensuring robust liquidity. The combination of strong operating cash generation and minimal investment requirements has enabled aggressive capital returns through both dividends and buybacks, though the low investment rate may constrain long-term growth capacity.
Ordinary income of 5.5B yen versus operating income of 5.5B yen shows minimal non-operating contribution of approximately 0.02B yen, indicating core earnings primarily drive overall profitability. Non-operating income composition includes interest and dividend income as well as equity method investment gains, representing less than 1% of revenue and having negligible impact on earnings profile. The small gap between operating and ordinary income confirms that earnings quality is primarily determined by core business performance rather than financial or non-operating items. Operating cash flow of 5.4B yen exceeds net income of 3.6B yen by 1.51x, indicating healthy earnings quality with profits backed by actual cash generation. This cash conversion ratio above 1.0x and above industry median suggests no material accruals manipulation concerns. The declining operating margin despite revenue growth warrants monitoring, as it may signal underlying business model pressure. Goodwill balance of 12.4B yen representing 52.4% of net assets creates latent earnings quality risk, as any future impairment would directly impact net income without corresponding cash outflow. No impairment losses or material non-recurring items were reported in the current period.
Full-year forecast projects revenue of 140.7B yen, operating income of 6.7B yen, ordinary income of 6.7B yen, and net income of 4.1B yen. Q3 cumulative progress rates are: revenue 75.0%, operating income 82.2%, ordinary income 81.9%, and net income 87.0%. Revenue progress aligns with the standard 75% benchmark for Q3, indicating on-track performance. Operating income and ordinary income show faster progress at approximately 82%, suggesting stronger-than-expected profitability in the first nine months. Net income progress of 87.0% substantially exceeds the Q3 standard of 75%, indicating front-loaded earnings or conservative full-year guidance. The company revised full-year forecasts with expected YoY changes of revenue +2.4%, operating income -4.2%, and ordinary income -0.8%, reflecting cautious outlook for operating profitability despite revenue growth expectations. The guidance implies Q4 will see lower margins than Q1-Q3 average, with operating income expected to contribute only 1.2B yen in Q4 versus 5.5B yen achieved in first nine months. This conservative Q4 outlook may reflect seasonality, planned investments, or management conservatism. Dividend forecast of 11 yen per share in the full-year guidance appears inconsistent with the disclosed interim dividend of 10 yen and expected year-end dividend of 10 yen (totaling 20 yen), requiring clarification.
Annual dividend is maintained at 20 yen per share (interim 10 yen, year-end 10 yen), unchanged from prior year level. Based on Q3 cumulative net income of 3.6B yen and assuming full-year net income of 4.1B yen as guided, the payout ratio calculates to approximately 53.1%, representing moderate shareholder return commitment. Share buyback activity continued during the period, with treasury stock increasing from negative 1.4B yen to negative 2.1B yen, representing approximately 0.7B yen of repurchases. Free cash flow of 4.7B yen provides coverage of 2.47x against dividends, indicating strong sustainability of current dividend level. Total shareholder return combining dividends and buybacks demonstrates management's capital allocation priority toward returning cash to shareholders. The total return approach balances steady dividends with flexible buybacks, allowing capital efficiency optimization while maintaining consistent per-share payments. With operating cash flow of 5.4B yen substantially exceeding capital requirements, the company maintains financial capacity to sustain both dividend payments and opportunistic share repurchases. However, the extremely low capex-to-depreciation ratio of 0.20x suggests potential underinvestment in business infrastructure, which may eventually constrain growth and future return capacity if not addressed.
Margin compression risk from low gross profit margin of 16.4% substantially below industry norms, exposing the company to operational leverage pressure if revenue growth slows or cost inflation accelerates. Personnel cost inflation in medical and elderly care sectors could further compress already thin margins, particularly given labor-intensive service model. Regulatory changes in healthcare reimbursement rates or elderly care subsidies could materially impact revenue and profitability across core segments.
Goodwill impairment risk from goodwill balance of 12.4B yen representing 52.4% of net assets, creating material downside to book value and earnings if acquired businesses underperform. Single impairment event could eliminate multiple years of accumulated earnings given current net income run-rate of approximately 4-5B yen annually.
Human capital and service quality risk in healthcare and elderly care businesses where personnel availability and quality directly determine service delivery capacity and customer satisfaction. Labor shortages in nursing and medical support fields could constrain growth, increase wage costs, or compromise service standards, impacting both revenue potential and profitability.
[Industry Position] (Reference - Proprietary Analysis)
The company operates in the IT and telecommunications services industry benchmark cohort. Profitability positioning shows ROE of 15.1% substantially exceeding industry median of 8.2% (2025-Q3, n=103), placing the company in the upper quartile. However, this elevated ROE is primarily driven by high financial leverage of 2.91x versus industry median of 1.66x, rather than superior operating profitability. Operating margin of 5.2% is significantly below industry median of 8.0%, positioning the company in the lower half of peers on core profitability. Net profit margin of 3.4% also trails industry median of 5.8%, confirming below-average profit generation efficiency.
Financial health indicators show equity ratio of 34.4% substantially below industry median of 59.0%, reflecting more aggressive capital structure. Current ratio of 131.8% is below industry median of 213%, though still adequate for liquidity needs. The company's higher leverage strategy amplifies ROE but increases financial risk relative to more conservatively capitalized peers.
Efficiency metrics demonstrate competitive advantages, with asset turnover of 1.54x more than double the industry median of 0.68x, reflecting superior asset utilization characteristic of service-focused business model. Revenue growth of 2.6% YoY significantly lags industry median of 10.4%, indicating slower top-line expansion. The combination of below-median profitability margins with above-median asset turnover suggests a volume-oriented strategy with constrained pricing power.
Industry: IT and Telecommunications Services (n=103 companies), Comparison period: 2025-Q3, Source: Proprietary analysis
Strong cash generation capability despite modest profitability, with operating cash flow to net income ratio of 1.51x exceeding industry median of 1.31x and free cash flow of 4.7B yen supporting sustainable capital returns. The company demonstrates consistent ability to convert earnings into cash, enabling both dividend payments and share buybacks while maintaining strong liquidity position with cash coverage of 24.8x short-term obligations.
Structural profitability challenges reflected in operating margin of 5.2% and gross margin of 16.4%, both substantially below industry benchmarks, combined with declining margin trend (down 0.3 percentage points YoY). Revenue growth of 2.6% significantly trails industry median of 10.4%, while operating profit declined 1.9% YoY, creating a concerning divergence that suggests pricing pressure or cost structure disadvantages in core medical and elderly care segments.
Material capital allocation and asset quality concerns arising from goodwill representing 52.4% of net assets creating significant impairment risk, combined with capex-to-depreciation ratio of 0.20x indicating systematic underinvestment in business infrastructure. High financial leverage of 2.91x versus industry median of 1.66x amplifies ROE to 15.1% but increases balance sheet risk, while extremely low investment rate raises questions about long-term competitive position maintenance and growth sustainability.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.